|
Dorothy M. Adcock, M.D.
Medical Director, Coagulation
Dot Adcock is a leading expert in coagulation and Medical Director in Aurora,
Colorado. Dr. Adcock holds board certification in Anatomic and Clinical
Pathology. Prior to joining Esoterix, Dr. Adcock was employed by the Colorado
Permanente Medical Group as a Staff Pathologist and previously served as
Regional Departmental Chief of Pathology. Dr. Adcock holds a faculty appointment
at the University of Colorado. Dr. Adcock is a member of the Clinical Laboratory
Standards Institute (CLSI) Area Committee on Hematology and has authored a
number of CLSI guidelines. Involved in committees for both the American Society
of Clinical Pathologists and College of American Pathologists, Dr. Adcock is
also secretary of the North American Specialized Coagulation Association
(NASCOLA) and serves as a member of the FDA Hematology and Pathology Devices
Panel. Dr. Adcock received her M.D. from Michigan State
University.
Galina I. Bannykh, M.D.
Staff Surgical Pathologist, Pathology
Galina Bannykh, Staff Surgical Pathologist, holds board certification in Anatomic and Clinical Pathology. Dr. Bannykh received her surgical pathology training at the University of California, San Diego. She then performed a fellowship in oncologic pathology at Memorial Sloan-Kettering in New York. Dr. Bannykh received her M.D. from the Ivanovo State Medical School in Ivanovo, Russia.
Charles P. Cartwright
Chief Scientific Officer, ViroMed Laboratories
Dr. Cartwright earned his doctorate in Microbiology from the University of Bath in the United Kingdom. After undertaking programs of post-doctoral research in Molecular Microbiology at Yale University School of Medicine and the University of Massachusetts Medical School, he completed a formal fellowship in Clinical Microbiology at the National Institutes of Health. During his tenure at the NIH, Dr. Cartwright was responsible for introducing molecular diagnostic testing into the Microbiology Service. Dr. Cartwright was then employed as a Senior Research Scientist in the Nucleic Acid Diagnostics Program at Ortho-Clinical Diagnostics in Rochester, NY before moving to Minneapolis, where for almost a decade he served on the faculty of the departments of Lab. Medicine and Pathology and Medicine at the University of Minnesota Medical School, and as Medical Director of Clinical Microbiology and Molecular Diagnostics at Hennepin County Medical Center and the Veterans Affairs Medical Center. Dr. Cartwright has published more than 50 papers in the fields of molecular biology and microbiology, and holds a published patent for the molecular detection of Mycobacterium avium complex. He is a member of the American Society for Microbiology and the Association for Molecular Pathology, and a former president of the Minnesota Inter-Laboratory Microbiology Association. As Chief Scientific Officer for ViroMed Laboratories, Dr. Cartwright will oversee the scientific integrity of testing at ViroMed and the introduction of new tests and technologies into the laboratory, as well as providing clinical consultations regarding the use and interpretation of tests.
D. Walt Chandler, Ph.D.
Executive Director, Endocrinology
Walt Chandler is Chief Scientific Officer for Endocrinology. Dr. Chandler has over 30 years of experience in diagnostic testing of steroid hormones and has been published in numerous professional journals. Dr. Chandler is a member of the Endocrine Society, the American Society for Mass Spectrometry, and the American Association of Clinical Chemistry. Dr. Chandler is a past recipient of the National Institutes of Health Cell and Molecular Biology National Research Service Award. He received his Ph.D. in Biochemistry from the University of California, Los Angeles.
Kelly Y. Chun, Ph. D.
Associate Director, Endocrinology
Kelly Chun is Associate Director of Endocrinology. She has authored many publications with a focus on clinical biochemistry and molecular biology and has served as a reviewer for number of scientific journals. She has extensive research experience in protein science and has developed and validated several pivotal endocrine assays for pharmaceutical trials. Dr. Chun received her Ph.D. in Biochemistry from the Medical College of Wisconsin and completed her Postdoctoral Clinical Chemistry Fellowship at Harvard Medical School.
Frank K. Fujimura, Ph.D.
Executive Director of Molecular Genetics
Frank Fujimura is Executive
Director of Molecular Genetics for Esoterix. He has over 15 years of
experience in clinical molecular genetics testing. Dr. Fujimura is board certified in
clinical molecular genetics by the American Board of Medical Genetics. He is a
member of numerous professional organizations including the American Association
of Clinical Chemistry, American College of Medical Genetics, and American
Society of Human Genetics. Dr. Fujimura received his Ph.D. in Biology from the
University of California, San Diego.
Russell P. Grant, Ph. D.
Director of Mass Spectrometry, Center for Innovation
Russell Grant is Director of Mass Spectrometry for the center of
Innovation. Dr. Grant has over 15 years experience in mass spectrometry
testing, including pharmaceutical drug discovery and development as a technical
director for Eli Lilly and senior scientist for GSK. Dr Grant has been
integral in the development and commercialization of a number of state of the
art instruments for major manufacturers, including ARIA transcend TX4 LC systems
and API5000 mass spectrometers. Dr Grant has published in a wide variety
of journals and regularly presents at international meetings such as the
american society for mass spectrometry (ASMS), Pittcon and AACC. Dr Grant
is intimately involved in multiple collaborations with academic groups and
manufacturers to provide next generation mass spectrometric technologies and
applications in diagnostic testing. Dr Grant received his Ph.D. in
Chromatographic and Mass Spectrometric Techniques from Swansea University,
Wales.
Michael Loeffelholz, Ph.D., D(ABMM)
Director of Scientific Development
Dr. Loeffelholz received his B.S. in Microbiology from the University of Iowa, and a Ph.D. in Microbiology from Ohio University. He completed a post-doctoral fellowship in medical and public health microbiology at Strong Memorial Hospital, University of Rochester, New York. Dr. Loeffelholz is board certified and a Diplomate of the American Board of Medical Microbiology. He has 18 years of laboratory experience including work in diagnostic product development and clinical and public health laboratories. He has authored over 100 scientific papers, abstracts, study courses, and book chapters and has served on the editorial boards for several scientific journals including the Journal of Clinical Microbiology. Dr. Loeffelholz has served on a number of committees for the American Society for Microbiology (ASM), Clinical Laboratory Standards Institute (CLSI, formerly NCCLS) and the Association of Public Health Laboratories.
Kenneth J. Pennline, Ph.D.
Vice President Scientific Affairs - Global Director Sales and Marketing, Clinical Trials
Ken Pennline is Executive Director of Scientific Affairs for Clinical Trials. Dr. Pennline is a member of the Society for Analytical Cytology, the American Association of Immunologists, the American Society for Microbiology, and the Drug Information Association. He has been published in numerous journals including Cytometry, Journal of Clinical Immunology, Immunopathology, Immunopharmacology, and Methods in Molecular Biology. Dr. Pennline received his Ph.D. in Immunology from The Ohio State University and completed a two-year postdoctoral fellowship program in the Department of Microbiology and Immunology at Georgetown University, Washington, D.C.
Stefan Tiefenbacher, Ph.D.
Scientific Director, Coagulation
Stefan Tiefenbacher is Scientific Director for Coagulation. Dr. Tiefenbacher brings over 10 years of research experience to Esoterix including fellowships from Harvard Medical School and more recently, the University of Colorado Health Science Center/Department of Psychiatry. He has extensive experience in assay development and validation for both pre-clinical and clinical applications. His diverse academic and professional development includes use of pharmacological, endocrine, molecular, behavioral and cognitive approaches. Dr. Tiefenbacher earned his Ph.D. in Neuroscience and Behavior from the University of Massachusetts, Amherst, MA. and holds a Masters Degree in Biology from the University of Konstanz, Germany.
|
